Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,409 | -8,265 | -15,304 | -9,816 | -5,259 |
| Depreciation Amortization | 995 | 497 | 2,012 | 1,509 | 1,007 |
| Income taxes - deferred | N/A | N/A | 26 | N/A | N/A |
| Accounts receivable | 41 | -410 | -401 | -350 | -333 |
| Other Working Capital | -1,064 | -1,732 | -1,277 | -1,739 | -2,355 |
| Other Operating Activity | 1,687 | 4,471 | -4,811 | -4,825 | -3,015 |
| Operating Cash Flow | $-10,751 | $-5,438 | $-19,756 | $-15,222 | $-9,955 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -594 | -838 | -11,089 | -4,029 | -3,926 |
| PPE Investments | -203 | -96 | -161 | -114 | -96 |
| Purchase Sale Intangibles | 150 | 150 | 350 | 350 | 250 |
| Other Investing Activity | 150 | 150 | 350 | 350 | 250 |
| Investing Cash Flow | $-647 | $-784 | $-10,900 | $-3,793 | $-3,772 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 28,011 | 24,322 | 24,322 |
| Financing Cash Flow | $N/A | $N/A | $28,011 | $24,322 | $24,322 |
| Exchange Rate Effect | 0 | 1 | -3 | -4 | 1 |
| Beginning Cash Position | 17,350 | 17,350 | 19,999 | 19,999 | 19,999 |
| End Cash Position | 5,952 | 11,129 | 17,350 | 25,303 | 30,594 |
| Net Cash Flow | $-11,398 | $-6,221 | $-2,648 | $5,304 | $10,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,751 | -5,438 | -19,756 | -15,222 | -9,955 |
| Capital Expenditure | -203 | -96 | -161 | -114 | -96 |
| Free Cash Flow | -10,954 | -5,534 | -19,917 | -15,336 | -10,051 |